Cell2in Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Out of Business

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Out of Business

Cell2in General Information

Description

Operator of a biopharmaceutical research and development center intended to safely measure the glutathione level in living cells. The company provides an unprecedented cell quality control method with potential applications in cell culture, cell therapy manufacturing, and diagnostics of various age-related diseases, enabling scientists to measure the quality of therapeutic cells.

Contact Information

Website
cell2in.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 14th floor, 190, Yulgok-ro
  • Jongro-gu
  • Seoul, 03127
  • South Korea
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 14th floor, 190, Yulgok-ro
  • Jongro-gu
  • Seoul, 03127
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cell2in Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 18-Aug-2025 Completed Out of Business
9. Early Stage VC (Series A) 01-Nov-2020 Completed Generating Revenue
8. Grant 01-May-2020 Completed Generating Revenue
7. Grant 01-Aug-2019 Completed Generating Revenue
6. Early Stage VC 01-Dec-2018 Completed Generating Revenue
5. Grant 01-Jan-2018 Completed Generating Revenue
4. Early Stage VC 01-Aug-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Early Stage VC 01-Sep-2016 $448.68 $448.68 Completed Generating Revenue
1. Grant 01-Jan-2016 $2.54K Completed Generating Revenue
To view Cell2in’s complete valuation and funding history, request access »

Cell2in Patents

Cell2in Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025063804-A1 Canine placenta-derived mesenchymal stem cells and use thereof Inactive 19-Sep-2023
US-20240021292-A1 Method of caring for psychological status based on biometric information and apparatus for performing the same Active 11-Feb-2022
EP-4269606-A1 Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same Inactive 22-Dec-2020
EP-4269606-A4 Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same Inactive 22-Dec-2020
US-20250164484-A1 Marker for selecting high-quality stem cells, and method for selecting high-quality stem cells using same Pending 22-Dec-2020 G01N33/56966
To view Cell2in’s complete patent history, request access »

Cell2in Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cell2in FAQs

  • When was Cell2in founded?

    Cell2in was founded in 2016.

  • Where is Cell2in headquartered?

    Cell2in is headquartered in Seoul, South Korea.

  • What is the size of Cell2in?

    Cell2in has 20 total employees.

  • What industry is Cell2in in?

    Cell2in’s primary industry is Drug Discovery.

  • Is Cell2in a private or public company?

    Cell2in is a Private company.

  • What is Cell2in’s current revenue?

    The current revenue for Cell2in is .

  • How much funding has Cell2in raised over time?

    Cell2in has raised $3.24K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process